Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and effectiveness of intravitreal bevacizumab and ranibizumab injections for retinal diseases
TCTR20141002001Completed
- Sponsor
- Health Intervention and Technology Assessment Program
- Start
- Jan 2013
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of bevacizumab and ranibizumab in retinal diseases (2 arms), sponsored by Health Intervention and Technology Assessment Program. Started Jan 2013; status: completed.
02
Drugs
bevacizumabranibizumab
03
Conditions
retinal diseases
Beyond the preview
Go deeper on TCTR20141002001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20141002001.